GB201310290D0 - Method for determining a probability of a major adverse cardiac event (MACE) - Google Patents

Method for determining a probability of a major adverse cardiac event (MACE)

Info

Publication number
GB201310290D0
GB201310290D0 GBGB1310290.0A GB201310290A GB201310290D0 GB 201310290 D0 GB201310290 D0 GB 201310290D0 GB 201310290 A GB201310290 A GB 201310290A GB 201310290 D0 GB201310290 D0 GB 201310290D0
Authority
GB
United Kingdom
Prior art keywords
mace
probability
determining
cardiac event
major adverse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1310290.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Manchester
Original Assignee
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Manchester filed Critical University of Manchester
Priority to GBGB1310290.0A priority Critical patent/GB201310290D0/en
Publication of GB201310290D0 publication Critical patent/GB201310290D0/en
Priority to PCT/GB2014/051250 priority patent/WO2014199119A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Physiology (AREA)
  • Artificial Intelligence (AREA)
  • Cell Biology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Signal Processing (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
GBGB1310290.0A 2013-06-10 2013-06-10 Method for determining a probability of a major adverse cardiac event (MACE) Ceased GB201310290D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1310290.0A GB201310290D0 (en) 2013-06-10 2013-06-10 Method for determining a probability of a major adverse cardiac event (MACE)
PCT/GB2014/051250 WO2014199119A1 (fr) 2013-06-10 2014-04-22 Procédé de détermination d'une probabilité d'un événement cardiaque majeur indésirable (mace)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1310290.0A GB201310290D0 (en) 2013-06-10 2013-06-10 Method for determining a probability of a major adverse cardiac event (MACE)

Publications (1)

Publication Number Publication Date
GB201310290D0 true GB201310290D0 (en) 2013-07-24

Family

ID=48876016

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1310290.0A Ceased GB201310290D0 (en) 2013-06-10 2013-06-10 Method for determining a probability of a major adverse cardiac event (MACE)

Country Status (2)

Country Link
GB (1) GB201310290D0 (fr)
WO (1) WO2014199119A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
PT3093663T (pt) * 2008-04-18 2018-10-19 Critical Care Diagnostics Inc Previsão do risco de eventos cardíacos adversos maiores

Also Published As

Publication number Publication date
WO2014199119A1 (fr) 2014-12-18

Similar Documents

Publication Publication Date Title
HK1220765A1 (zh) 對樣本成像的方法
HK1226484A1 (zh) 預測出現主要不良心臟事件的風險的方法
GB2570066B (en) Method for determining location of wireless devices
GB201401248D0 (en) Method of manufacture
PT3005298T (pt) Método de reconstrução de um objeto a partir de visualizações de projeção
EP2954725A4 (fr) Solution améliorée pour un transfert intercellulaire
LU92173B1 (en) Distance determination method
ZA201600018B (en) Method for improving adherence
EP2982787A4 (fr) Procédé pour tricoter un article chaussant
DK2879615T3 (da) Fremgangsmåde til at bestemme sandsynlighed for brunst
GB201412190D0 (en) Method of optimization for an application
EP3753596C0 (fr) Procédé de fabrication d'un dispositif de gestion des voies aériennes
HK1222094A1 (zh) 動物加工的方法
GB2530701B (en) Method for establishment of a new well path from an existing well
SG11201601261SA (en) Etching method
SG11201600696PA (en) Etching method
SG11201509106WA (en) Method of processing a transaction request
GB201322931D0 (en) Method of etching
GB201305231D0 (en) Method of Manufacture
PL2889638T3 (pl) Sposobu używania radaru pasywnego
GB201321349D0 (en) Trustworthiness of processed data
PL2799237T3 (pl) Sposób wytwarzania elastycznego laminatu
GB201302281D0 (en) Method of manufacturing a beam
GB201305695D0 (en) A method of forming an article
ZA201601560B (en) Probability of inhibition prediction

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)